 BREA, Calif., Sept. 7, 2021 PRNewswire -- Envista Holdings Corporation NYSE: NVST Envista today announced it entered into a binding agreement to sell its KaVo Treatment Unit and Instrument business to planmeca Verwaltungs GmbH Planmeca for up to 455 million, which includes a potential earn-out payment of up to 30 million. 